The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.75
Bid: 31.50
Ask: 32.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.587%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 31.75
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Royalty Finance Agreement

5 Mar 2018 07:00

RNS Number : 6117G
Duke Royalty Limited
05 March 2018
 

5 March 2018

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

 

New Royalty Agreement with Birmingham-based Specialist Coatings Manufacturer

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has entered into a £9 million royalty financing agreement (the "Financing") with Trimite Global Coatings Limited ("Trimite"), a Birmingham-based specialist coatings manufacturer established in the 1940s.

 

In addition, the Company is pleased to announce that it has entered into non-binding terms with a fourth Royalty Partner and is also pleased to publish an updated unaudited balance sheet to better reflect its current financial position following its £20 million equity financing completed in December 2017.

 

Highlights

 

· Duke has committed £9.0 million to Trimite, its third royalty financing agreement in Europe, providing it with the necessary funds to buy-out a minority shareholder, to fund a small bolt-on acquisition and to provide the additional working capital required to fund its anticipated future organic sales growth

· Initial cash-on-cash yield of over 13 per cent. via monthly payments

· 30 year secured financing - distributions to be adjusted annually to reflect Trimite revenue growth

· 2.5 per cent. equity interest in Trimite granted at no additional consideration

· Trimite is a profitable supplier of industrial coatings to global brands and organisations

· 120 employees across four UK plants and a highly experienced management team

· The Financing meets Duke's strategy to replicate the proven North American royalty model to create long term value for shareholders in the form of predictable, robust dividend streams 

· Non-binding terms signed with a fourth Royalty Partner, a long established and profitable UK-based glass processing business

 

Neil Johnson, CEO of Duke Royalty, said: 

 

"We have been working closely with Trimite for some time to execute this Financing. With a solid sales pipeline and a high-quality management team who are also investing their capital in the business, we feel that Trimite represents a textbook deal for Duke.

 

"In addition, we are pleased with the progress we are experiencing in terms of our future pipeline of deal opportunities and are confident that royalty financing will become increasingly understood as a highly competitive form of growth capital across our preferred sectors."

 

David Roberts, Chairman and majority shareholder of Trimite, said: 

 

"Trimite investigated a number of different financing alternatives and decided upon the Duke proposal as a result of the long term, participating nature of the investment, which removes any short term refinancing risk. Trimite looks forward to a long and positive partnership with Duke as we grow our business."

 

New Royalty Partner - Trimite Global Coatings Limited

www.trimite.com

 

As detailed on 4 December 2017 at the time of its £20 million equity fundraising, Duke has been working on an investment opportunity to provide royalty financing to a speciality coating manufacturer. This investment, which has been entered into with Trimite, has now completed, utilising the proceeds of the Company's equity financing in December.

 

Trimite is a 70-year-old UK private company that formulates and manufactures high performance and technologically superior coatings and paints for speciality industrial markets. It has more than 120 employees in four UK plants based in Birmingham, the Midlands and West London.

 

Trimite is a key supplier of industrial coatings to several global brands and organisations in sectors including defence and aerospace, agricultural and construction equipment, and automotive. Trimite has a history of profitable operations in highly technical applications, has low debt and enjoys robust gross margins relative to the overall paint industry.

 

Trimite is majority-owned by Chairman David Roberts and led by a highly experienced team of executives who have spent their careers in the UK manufacturing sector and in senior management positions in global coatings suppliers like Akzo Nobel. With this in mind, Trimite is well-positioned to expand its market presence and take advantage of its strong and growing sales pipeline.

 

About the Financing

 

Duke has committed £9.0 million, providing it with the necessary funds to buy-out a minority shareholder, to fund a small bolt-on acquisition and to provide the additional working capital required to fund its anticipated future organic sales growth.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in March 2018. On an annual basis, the initial Distribution is expected to total approximately £1.2 million, equating to a cash-on-cash yield of over 13 per cent.

 

The Distribution will be adjusted annually with the first adjustment occurring in April 2019 based on the percentage change in Trimite's gross revenues for the year to 31 March 2019 compared to the prior financial year. The annual adjustment in the Distribution will be subject to a collar. The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Trimite utilises an early buyback option.

 

Concurrent to the Financing, Trimite has secured an investment from its Chairman for £2 million at an indicative pre-money valuation of £15 million and Trimite has agreed to issue Duke, for no additional consideration, with an equity interest of 2.5 per cent. of the ordinary shares of the enlarged group.

 

Update on identified near term investment opportunity

 

As detailed on 4 December 2017, Duke has been actively progressing a potential fourth investment into a long established and profitable UK glass processing business.

 

Duke is pleased to report that non-binding terms have now been agreed and are in line with Duke's typical deal structure, which includes senior security, an over 13 per cent. initial cash-on-cash yield, an annual adjustment factor based on revenue performance, and a 30-year term.

 

While the transaction is subject to due diligence and final documentation, Duke is confident that it will be able to complete the transaction by April 2018 as previously announced.

 

Duke Royalty portfolio

 

Further to the completion of the Trimite Financing the Company's portfolio of royalty investments is as follows with over £23 million of capital deployed to date:

 

Royalty Partner

Royalty investment amount

Date of Royalty Agreement

Temarca B.V

Euro 8,000,000

April 2017

Lynx Equity (UK) Limited

GBP 7,000,000

October 2017

Trimite Global Coatings Limited

GBP 9,000,000

March 2018

 

 

Unaudited Company balance sheet as at 31 January 2018

 

To more accurately reflect the financial position of Duke following the fundraising in December 2017, the Company reports its latest unaudited balance sheet as at 31 January 2018.

 

CONSOLIDATED BALANCE SHEET

AS AT 31 JANUARY 2018

£

ASSETS

Royalty debt instruments

14,556,739

Equity investments at fair value through profit and loss

-

Total non-current assets

14,556,739

Trade and other receivables

308,963

Cash and cash equivalents

18,233,882

Total current assets

18,542,845

33,099,584

EQUITY AND LIABILITIES

Equity

Shares issued

60,391,300

Shares to be issued

-

Share option reserve

124,412

Retained losses

(27,464,244)

Total equity

33,051,468

Current liabilities

Trade and other payables

48,116

Total current liabilities

48,116

Total equity and liabilities

33,099,584

 

**ENDS**

 

For further information, please contact www.dukeroyalty.com, or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

 

+44 (0) 1481 741 240

Grant Thornton UK LLP 

(Nominated Adviser)

Colin Aaronson / Samantha

Harrison / Carolyn Sansom

 

+44 (0) 20 7383 5100

 

Cenkos Securities plc 

(Joint Broker)

 

Julian Morse / Michael Johnson

+44 (0) 207 397 8900

Mirabaud Securities Limited

(Joint Broker)

 

Peter Krens / Edward Haig-Thomas

 

+44 (0) 20 3167 7222

Redleaf Communications

(PR)

 

Elisabeth Cowell/ Robin Tozer/ Ian Silvera

+44 (0) 20 3757 6880

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

 

Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGREAKDLEFAPEFF
Date   Source Headline
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat
6th Mar 20247:00 amRNSSuccessful Exit of Investment
4th Mar 20247:00 amRNSIncreased Equity Stake in United Glass Group
21st Feb 202411:57 amRNSName Change Effective
20th Feb 202412:08 pmRNSResult of General Meeting & Change of Name
5th Feb 20247:00 amRNSProposed Change of Name, Website and Messaging
29th Dec 20237:00 amRNSTrading Update and Follow-on Investment
19th Dec 20237:00 amRNSInterim Dividend and Dividend Declaration
29th Nov 20237:00 amRNSUpdate re. Change of Name of Nominated Adviser
22nd Nov 20237:00 amRNSFinancial Year 2024 Interim Results
21st Sep 20237:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20237:00 amRNSTrading Update
2nd Aug 20234:51 pmRNSResult of Annual General Meeting
31st Jul 20237:00 amRNSNew Royalty Agreement
28th Jul 20237:00 amRNSDirector/PDMR Dealings
20th Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
4th Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
3rd Jul 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
26th Jun 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
15th Jun 20237:00 amRNSInterim Dividend and Dividend Declaration
9th Jun 20237:00 amRNSNotice of Results
1st Jun 20237:00 amRNSTrading Update
25th May 20237:00 amRNSDirectors' Dealings
24th May 20237:00 amRNSSuccessful Exit of Investment in Royalty Partner
22nd Mar 20237:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20237:00 amRNSNew Royalty Agreement
3rd Mar 20237:00 amRNSTrading Update
21st Feb 20237:00 amRNSFollow-On Investment into Existing Royalty Partner
16th Jan 20237:00 amRNSClosing of New Credit Facility
15th Dec 20223:35 pmRNSInterim Dividend and Dividend Declaration
13th Dec 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
12th Dec 20227:00 amRNSRefinance and Upsize of Credit Facility
1st Dec 20227:01 amRNSTrading Update
1st Dec 20227:00 amRNS2023 Interim Results
29th Nov 202212:38 pmRNSResult of Annual General Meeting
25th Nov 20227:00 amRNSNew Royalty Agreement
14th Nov 20227:00 amRNSNotice of AGM and Notice of Interim Results
14th Oct 20227:00 amRNSPSAs, Issue of Equity & Director/PDMR Dealings
22nd Sep 20227:00 amRNSInterim Dividend and Dividend Declaration
13th Sep 20229:09 amRNSPublication of Annual Report & Accounts
9th Sep 20227:00 amRNSPostponement of Presentation
8th Sep 20227:00 amRNSFinal Results for the year ended 31 March 2022
31st Aug 20225:04 pmRNSHolding(s) in Company
30th Aug 20223:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.